GT Biopharma Inc.
2.36
-0.16 (-6.35%)
At close: Jan 15, 2025, 3:59 PM
2.30
-2.54%
After-hours Jan 15, 2025, 06:41 PM EST

GT Biopharma Inc. Forecast

Stock Price Forecast

The 1 analysts with 12-month price forecasts for GTBP stock have an median target of 11, with a low estimate of 11 and a high estimate of 11. The median target predicts an increase of 366.10% from the current stock price of 2.36.

Analyst Consensus: Buy
Target Low Average Median High
Price $11 $11 $11 $11
Change 366.10% 366.10% 366.10% 366.10%

AI Analyst Report

According to 1 stock analyst, the rating for GT Biopharma Inc. is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.

Rating Dec 24
Strong Buy 0
Buy 1
Hold 0
Sell 0
Strong Sell 0
Total 1

Financial Forecast this Year

Revenue This Year
13.00M
from 0
Increased by -%
Revenue Next Year
13.50M
from 13.00M
Increased by 3.8%
EPS This Year
-6.79
from -5.64
Increased by -20.4%
EPS Next Year
-2.11
from -6.79
Increased by 68.9%